Soligenix Statistics
NASDAQ: SNGXHealthcareBiotechnologyUSD
0.3466-0.0069 (-1.95%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Soligenix by the numbers
Soligenix has a market capitalization of $7.5 million based on 21.77M shares outstanding. With trailing EPS of $-0.79, Soligenix is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.2% below its 50-day average and 54.9% below its 200-day average.
Average daily trading volume is 253.75K shares, or about $87,950 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SNGX valuation vs. peer median
| Metric | SNGX | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.54M | $7.53M | +0% |
| Avg. volume | 253.75K | 148.40K | +71% |
Peer median across 8 companies: FBLG, CNSP, LGVN, CLGN, CURX, SKYE, AZTR, TRAW.
Valuation
- Market cap
- $7.54M
- EPS (TTM)
- $-0.79
- Shares outstanding
- 21.77M
Price and trading
- Previous close
- 0.3535
- Open
- 0.36
- Day range
- 0.345 – 0.3627
- 52-week range
- 0.28 – 1.97
- 50-day moving average
- 0.3776
- 200-day moving average
- 0.7689
- Beta
- —
- Volume
- 120.15K
- Average volume
- 253.75K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 7.54M
- Forward Pe
- -1.39
- Eps
- -0.79
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.97
- Week52 Low
- 0.28
- Avg Volume
- 253.75K
- Shares Outstanding
- 21.77M
- Ma50
- 0.38
- Ma200
- 0.77
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -82.41%
- Pct From52w Low
- 23.79%